In recent trading session, Jasper Therapeutics Inc (NASDAQ:JSPR) saw 1.22 million shares changing hands at last check today with its beta currently measuring 2.21. Company’s recent per share price level of $6.75 trading at -$0.24 or -3.43% at last check today assigns it a market valuation of $101.26M. That most recent trading price of JSPR’s stock is at a discount of -359.41% from its 52-week high price of $31.01 and is indicating a premium of 2.07% from its 52-week low price of $6.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.96 million shares which gives us an average trading volume of 384.72K if we extend that period to 3-months.
For Jasper Therapeutics Inc (JSPR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -1.26 in the current quarter.
Jasper Therapeutics Inc (NASDAQ:JSPR) trade information
Upright in the red during last session for losing -3.43%, in the last five days JSPR remained trading in the red while hitting it’s week-highest on Friday, 01/03/25 when the stock touched $6.75 price level, adding 69.66% to its value on the day. Jasper Therapeutics Inc’s shares saw a change of -68.43% in year-to-date performance and have moved -67.99% in past 5-day. Jasper Therapeutics Inc (NASDAQ:JSPR) showed a performance of -69.87% in past 30-days. Number of shares sold short was 2.07 million shares which calculate 10.97 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 55.5 to the stock, which implies a rise of 87.84% to its recent value today. Analysts have been projecting 48 as a low price target for the stock while placing it at a high target of 63. It follows that stock’s current price would drop -611.11% in reaching the projected high whereas dropping to the targeted low would mean a loss of -611.11% for stock’s current value.
Jasper Therapeutics Inc (JSPR) estimates and forecasts
Statistics highlight that Jasper Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -66.33% of value to its shares in past 6 months, showing an annual growth rate of 27.51% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Jasper Therapeutics Inc (NASDAQ:JSPR)’s Major holders
Insiders are in possession of 1.28% of company’s total shares while institution are holding 98.74 percent of that, with stock having share float percentage of 100.02%. Investors also watch the number of corporate investors in a company very closely, which is 98.74% institutions for Jasper Therapeutics Inc that are currently holding shares of the company.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 401.22 shares of worth $2.77 million or 2.67% of the total outstanding shares. The later fund manager was in possession of 296.68 shares on Oct 31, 2024, making its stake of worth around $2.05 million in the company or a holder of 1.98% of company’s stock.
